John Theurer Cancer Center
Hospital in New Jersey, United States / From Wikipedia, the free encyclopedia
John Theurer Cancer Center (JTCC) at the Hackensack University Medical Center (HUMC), and part of the Hackensack Meridian Health (HMH), specializes in oncology services and treatments.[1] It is known for being the first site approved to use cell-based gene therapy to treat patients with certain types of large B-cell lymphoma who have not responded or relapsed after at least two other kinds of treatment; it initiated the first CAR T-cell therapy clinical trials and is a member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center. Other areas of concentration include bone marrow transplants, stem cell transplantation, lymphoma, leukemia, multiple myeloma, neuro-oncology, cutaneous malignancy, gastrointestinal, geriatric, head and neck, thoracic, urologic, breast, and gynecologic.[2] As of 2023, Andre Goy is chair and Chief Physician Officer.[3][4][5]
John Theurer Cancer Center | |
---|---|
Geography | |
Location | 92 2nd Street, Hackensack, New Jersey, United States |
Organization | |
Funding | Non-profit hospital |
Type | Cancer treatment |
Affiliated university | Hackensack University Medical Center
Georgetown Lombardi Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center |
Network | Hackensack Meridian Health |
Links | |
Lists | Hospitals in the United States |